Using TOfogliflozin for Possible better Intervention against Atherosclerosis for Type 2 Diabetes Patients
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2017
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Atherosclerosis; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms UTOPIA
- 01 Oct 2017 Trial design of the study published in the Diabetes Therapy.
- 08 May 2017 Status changed from recruiting to active, no longer recruiting.
- 20 May 2015 New trial record